Group One Trading’s Marker Therapeutics MRKR Stock Holding History
Bought
Maintained
Sold
Other funds holding MRKR
Group One Trading's MRKR Position: Q3 2026 in Review
Group One Trading held its Marker Therapeutics (MRKR) position steady in Q3 2026 at 178 shares worth $190. The position accounts for ﹤0.01% of the portfolio, ranked #7346.
Group One Trading first reported a position in MRKR in Q2 2019 and has held it in 24 quarters since. The position peaked at $70K in Q3 2019. 36 funds tracked by Wall St. Rank hold MRKR as of Q3 2026.
- Group One Trading held 178 shares of Marker Therapeutics worth $190 as of Q3 2026.
- Group One Trading left its Marker Therapeutics share count unchanged in Q3 2026.
- Marker Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #7346 holding.
- Group One Trading first reported a position in Marker Therapeutics in Q2 2019 and has held it in 24 quarters since.
- Group One Trading's Marker Therapeutics position peaked at $70K in Q3 2019.
- 36 funds tracked by Wall St. Rank held Marker Therapeutics as of Q3 2026.
Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.